However, Vilar-Gomez et al. discovered that patients with NAFLD and ADH1B*2 (mutant allele) had a decreased risk of steatohepatitis and fibrosis, and this protective effect remained significant even after controlling for alcohol consumption status, age, sex, and BMI. This evidence concerns the gene ADH1B and fibrosis.